GLP-1 (S)

GLP-1 (S)

Price range: $ 35 through $ 100

A GLP-1 receptor agonist that mimics the incretin hormone GLP-1. Originally developed for type 2 diabetes, now widely used for obesity management. Reduces appetite, slows gastric emptying, and improves insulin sensitivity

✓ Significant weight loss (15–20% body weight)
✓ Improved blood sugar control (HbA1c reduction)
✓ Reduced cardiovascular risk in diabetics
✓ Decreased appetite and cravings
✓ Improved lipid profile
• Nausea, vomiting, diarrhea (very common, especially when starting)
• Constipation
• Fatigue
• Injection site reactions
• Rare: pancreatitis, thyroid C-cell tumors (in rodents)
• Potential muscle mass loss with rapid weight loss
7 days
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.

GLP-1 (S)

Price range: $ 35 through $ 100

A GLP-1 receptor agonist that mimics the incretin hormone GLP-1. Originally developed for type 2 diabetes, now widely used for obesity management. Reduces appetite, slows gastric emptying, and improves insulin sensitivity

FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.
✓ Significant weight loss (15–20% body weight)
✓ Improved blood sugar control (HbA1c reduction)
✓ Reduced cardiovascular risk in diabetics
✓ Decreased appetite and cravings
✓ Improved lipid profile
7 days